Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ABRDN Physical Gold Shares ETF (SGOL) vs BIO-TECHNE Corp (TECH) Price & Performance

ABRDN Physical Gold Shares ETFTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

ABRDN Physical Gold Shares ETF vs BIO-TECHNE Corp — how do they compare? ABRDN Physical Gold Shares ETF trades at $38.89, while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp pays a 0.45% dividend while ABRDN Physical Gold Shares ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, ABRDN Physical Gold Shares ETF nearer its low. Which is the better fit depends on your goals.

SGOLTECH
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$51.41$72.12
52-Week Low
$31.18$43.31
Market Cap
$11.16B
Enterprise Value
$11.24B
Dividend Yield
0.45%

Returns comparison

Trailing returns across standard periods

About ABRDN Physical Gold Shares ETF

SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.

Read more on SGOL

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH